Aurora Cannabis Inc. (ACB) Cash Flow Statement

The roughly $72M gap between cumulative net losses and cumulative operating cash outflow is the single most important signal in this cash flow statement, because it implies that reported operating weakness is being partially offset by non-recurring balance sheet liquidation rather than by earnings quality. When working capital is stripped out, the underlying operating engine appears materially weaker than the headline OCF/NI ratio of 1.10 in 2027Q1 would suggest, given that net income itself was negative $4.0M. Investors should treat positive OCF printings here as evidence of asset monetization, not of a business approaching breakeven.

FCF has been negative in six of ten quarters, and the two most recent quarters (2026Q4 at -$5.4M and 2027Q1 at -$9.9M) show the deficit widening sequentially, which suggests the operating cash generation seen in mid-2025 has not proven durable. Critically, this burn is occurring even though capex is only modestly above depreciation, meaning the shortfall is structural rather than investment-driven, and it compounds the revenue collapse of 23.4% year-over-year already flagged in the income statement. Without a reversal in either working capital contribution or operating losses, the trajectory implies continued reliance on external financing or further asset sales.

Every quarter with a positive working capital contribution of $10M or more (2025Q3, 2026Q1, 2026Q3) coincided with positive OCF, while the two largest working capital drags (-$29.6M and -$36.4M) coincided with the deepest OCF losses, indicating that cash flow is being dictated by inventory and receivable liquidation rather than by operating performance. In a business whose revenue is structurally shrinking, this pattern likely reflects the natural unwinding of receivables and inventory pools, which is a finite and non-repeatable source of cash. The volatility of these swings—spanning roughly $52M between extremes—also raises questions about collection discipline and possible one-time settlement timing that warrants closer examination of the balance sheet.

The elevated CapEx/Revenue ratios in 2026Q4 (13.6%) and 2027Q1 (8.0%) appear to be less a function of aggressive expansion spending than of a collapsing denominator, which mechanically inflates capital intensity even as absolute capex stays in a relatively narrow $4.3M–$6.3M range. Relative to D&A, capex exceeded depreciation in 2027Q1 ($5.4M vs $4.0M) and most prior quarters, suggesting the company has been at least maintaining, and modestly growing, its asset base. This maintenance-level posture makes the persistent FCF deficit more concerning, as it implies the burn is operational rather than a discretionary growth investment that could be curtailed.

Deploying capital to M&A while core free cash flow remains negative suggests management is prioritizing inorganic growth or portfolio reshaping over cash preservation, a strategy that may prove defensible if the acquired assets generate immediate cash but materially raises execution risk given the ongoing operating burn. The complete absence of dividends and buybacks across ten quarters is consistent with a company in cash-preservation mode, which makes the $14.8M acquisition outflow stand out as a deliberate strategic choice rather than a residual allocation. Investors should scrutinize whether the acquired business unit is expected to contribute positive OCF, because if it inherits Aurora's existing cost structure, the transaction could extend rather than shorten the path to breakeven.